Literature DB >> 21986518

Failsafe program escape and EMT: a deleterious partnership.

Stéphane Ansieau1, Stéphanie Courtois-Cox, Anne-Pierre Morel, Alain Puisieux.   

Abstract

The epithelial to mesenchymal transition (EMT) is a latent embryonic process which can be aberrantly reactivated during tumor progression. It is generally viewed as one of the main forces driving metastatic dissemination, by providing cells with invasive and motility capabilities. The aberrant reactivation of embryonic EMT inducers has now been additionally linked to escape from senescence and apoptosis, which suggests a role in tumor initiation. This oncogenic potential relies on the ability of EMT inducers to neutralize both the RB and p53 oncosuppressive pathways. RB and p53 have recently been described as key factors in the maintenance of epithelial morphology, which suggests an unexpected and intimate crosstalk between EMT and the corresponding safety programs. In this review, we attempt to understand how these two cell processes are interlinked and might facilitate cell transformation and tumor initiation.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21986518     DOI: 10.1016/j.semcancer.2011.09.014

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  16 in total

1.  Soiling the seed: microenvironment and epithelial mesenchymal plasticity.

Authors:  Izhak Haviv; Erik W Thompson
Journal:  Cancer Microenviron       Date:  2012-04

2.  Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.

Authors:  Tatiana Franceschi; Emeline Durieux; Anne Pierre Morel; Pierre de Saint Hilaire; Isabelle Ray-Coquard; Alain Puisieux; Mojgan Devouassoux-Shisheboran
Journal:  Virchows Arch       Date:  2019-02-09       Impact factor: 4.064

3.  Inhibitory effects of Arhgap6 on cervical carcinoma cells.

Authors:  Junping Li; Yang Liu; Yihua Yin
Journal:  Tumour Biol       Date:  2015-12-01

4.  Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas.

Authors:  Feng He; Jonathan Melamed; Moon-Shong Tang; Chuanshu Huang; Xue-Ru Wu
Journal:  Cancer Res       Date:  2015-03-20       Impact factor: 12.701

5.  Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer.

Authors:  Francesca Corsi; Francesco Capradossi; Andrea Pelliccia; Stefania Briganti; Emanuele Bruni; Enrico Traversa; Francesco Torino; Albrecht Reichle; Lina Ghibelli
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

6.  High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.

Authors:  Cecilia W Huo; Grace Chew; Prue Hill; Dexing Huang; Wendy Ingman; Leigh Hodson; Kristy A Brown; Astrid Magenau; Amr H Allam; Ewan McGhee; Paul Timpson; Michael A Henderson; Erik W Thompson; Kara Britt
Journal:  Breast Cancer Res       Date:  2015-06-04       Impact factor: 6.466

7.  Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.

Authors:  Theodora Fifis; Linh Nguyen; Cathy Malcontenti-Wilson; Lie Sam Chan; Patricia Luiza Nunes Costa; Jurstine Daruwalla; Mehrdad Nikfarjam; Vijayaragavan Muralidharan; Mark Waltham; Erik W Thompson; Christopher Christophi
Journal:  Cancer Med       Date:  2013-08-18       Impact factor: 4.452

Review 8.  The structural basis for cancer treatment decisions.

Authors:  Ruth Nussinov; Hyunbum Jang; Chung-Jung Tsai
Journal:  Oncotarget       Date:  2014-09-15

9.  PTTG2 silencing results in induction of epithelial-to-mesenchymal transition and apoptosis.

Authors:  C Méndez-Vidal; M del Mar Gámez-Del Estal; M A Moreno-Mateos; A G Espina-Zambrano; B Torres; J A Pintor-Toro
Journal:  Cell Death Dis       Date:  2013-03-07       Impact factor: 8.469

Review 10.  Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT.

Authors:  Jenny G Parvani; William P Schiemann
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.